Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
NRDS
|
Topline Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 49,722 Added 0.0% |
$599,150
$12.05 p/Share
|
Oct 21
2024 |
NRDS
|
Topline Capital Partners, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 49,722 Added 1.02% |
$599,150
$12.05 p/Share
|
Oct 21
2024 |
AESI
|
Gregory M Shepard |
BUY
Open market or private purchase
|
Direct | 8,062 Added 0.11% |
$159,950
$19.84 p/Share
|
Oct 21
2024 |
PGR
|
Steven Broz
Chief Information Officer |
SELL
Open market or private sale
|
Direct | 2,981 Reduced 10.16% |
$748,678
$251.15 p/Share
|
Oct 21
2024 |
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 608 Reduced 0.81% |
$73,422
$120.76 p/Share
|
Oct 21
2024 |
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,709 Reduced 0.87% |
$206,378
$120.76 p/Share
|
Oct 21
2024 |
NTRA
|
Daniel Rabinowitz
SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 467 Reduced 0.22% |
$56,394
$120.76 p/Share
|
Oct 21
2024 |
ROIV
|
Eric Venker
President & COO |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 13.94% |
$1,165,000
$11.65 p/Share
|
Oct 21
2024 |
VRNA
|
Mark W Hahn
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 116,696 Reduced 0.83% |
$511,128
$4.38 p/Share
|
Oct 21
2024 |
VRNA
|
David Zaccardelli
President and CEO |
SELL
Open market or private sale
|
Direct | 110,456 Reduced 0.74% |
$483,797
$4.38 p/Share
|
Oct 21
2024 |
SCHW
|
Charles R. Schwab
Co-Chairman |
SELL
Open market or private sale
|
Indirect | 17,225 Reduced 0.0% |
$1,221,252
$70.9 p/Share
|
Oct 21
2024 |
PAYC
|
Chad R. Richison
CEO, President and Chairman |
SELL
Open market or private sale
|
Direct | 1,950 Reduced 0.07% |
$330,174
$169.32 p/Share
|
Oct 21
2024 |
PAYC
|
Chad R. Richison
CEO, President and Chairman |
SELL
Open market or private sale
|
Indirect | 1,950 Reduced 0.0% |
$330,174
$169.32 p/Share
|
Oct 21
2024 |
SEAT
|
Edward Pickus
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 542 Reduced 1.16% |
$2,216
$4.09 p/Share
|
Oct 21
2024 |
SEAT
|
Riva Bakal
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 1,730 Reduced 1.34% |
$7,075
$4.09 p/Share
|
Oct 21
2024 |
FBK
|
James W. Ayers
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.02% |
$96,340
$48.17 p/Share
|
Oct 21
2024 |
LPSN
|
Jeffrey Ford
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 21,935 Reduced 5.47% |
$25,005
$1.14 p/Share
|
Oct 21
2024 |
QLYS
|
Bruce K Posey
CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,339 Reduced 2.36% |
$165,888
$123.89 p/Share
|
Oct 21
2024 |
TYRA
|
Todd Harris
President and CEO |
SELL
Open market or private sale
|
Direct | 19,084 Reduced 1.39% |
$529,390
$27.74 p/Share
|
Oct 21
2024 |
ULY
|
Ben Volkow |
SELL
Open market or private sale
|
Direct | 15,200 Reduced 3.24% |
$10,032
$0.66 p/Share
|
Oct 21
2024 |
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 26,000 Added 0.0% |
$173,420
$6.67 p/Share
|
Oct 21
2024 |
HIMS
|
Michael Chi
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 3.72% |
$166,500
$22.2 p/Share
|
Oct 21
2024 |
FFIV
|
Francis J. Pelzer
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 600 Reduced 1.97% |
$130,601
$217.67 p/Share
|
Oct 21
2024 |
TRV
|
Diane Kurtzman
EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct | 3,941 Reduced 69.69% |
$1,026,315
$260.42 p/Share
|
Oct 21
2024 |
PLMR
|
Mac Armstrong
CEO and Chairman |
SELL
Open market or private sale
|
Indirect | 7,000 Reduced 0.0% |
$675,290
$96.47 p/Share
|
Oct 21
2024 |
TRV
|
Mojgan M Lefebvre
EVP & Chief Tech & Ops Officer |
SELL
Open market or private sale
|
Direct | 21,036 Reduced 100.0% |
$5,473,146
$260.18 p/Share
|
Oct 21
2024 |
RMCF
|
Jeffrey Richart Geygan
Interim CEO |
BUY
Open market or private purchase
|
Indirect | 7,409 Added 0.0% |
$17,188
$2.32 p/Share
|
Oct 21
2024 |
RMCF
|
Global Value Investment Corp. |
BUY
Open market or private purchase
|
Indirect | 7,409 Added 0.0% |
$17,188
$2.32 p/Share
|
Oct 21
2024 |
UTHR
|
James Edgemond
CFO AND TREASURER |
SELL
Open market or private sale
|
Direct | 7,782 Reduced 52.72% |
$2,855,916
$366.99 p/Share
|
Oct 21
2024 |
WBS
|
Albert Jen Wen Wang
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 21.89% |
$209,720
$52.43 p/Share
|
Oct 21
2024 |
WBS
|
Daniel Bley
Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 3,463 Reduced 15.06% |
$180,422
$52.1 p/Share
|
Oct 21
2024 |
BCOV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,500 Added 0.0% |
$7,280
$2.08 p/Share
|
Oct 21
2024 |
HSY
|
Steven E Voskuil
SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 3.1% |
$185,470
$185.47 p/Share
|
Oct 21
2024 |
SES
|
Sk Inc. |
SELL
Open market or private sale
|
Direct | 500,000 Reduced 1.31% |
$345,000
$0.69 p/Share
|
Oct 21
2024 |
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$1,524,505
$191.81 p/Share
|
Oct 21
2024 |
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$1,524,505
$191.81 p/Share
|
Oct 21
2024 |
HWC
|
Carleton Richard Wilkins
Director |
SELL
Open market or private sale
|
Direct | 800 Reduced 4.79% |
$40,760
$50.95 p/Share
|
Oct 21
2024 |
ACN
|
Julie Spellman Sweet
Chair and CEO |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 30.69% |
$3,385,980
$376.22 p/Share
|
Oct 21
2024 |
SLDB
|
Gabriel Brooks
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,923 Reduced 21.03% |
$18,999
$6.5 p/Share
|
Oct 21
2024 |
DYN
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect | 121 Reduced 0.0% |
$4,242
$35.06 p/Share
|
Oct 21
2024 |
TRV
|
Alan D Schnitzer
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 40,524 Reduced 15.44% |
$10,628,229
$262.27 p/Share
|
Oct 21
2024 |
TRV
|
Alan D Schnitzer
Chairman and CEO |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$2,621,000
$262.1 p/Share
|
Oct 21
2024 |
IDT
|
Menachem Ash
EVP of Strategic&Legal Affairs |
SELL
Open market or private sale
|
Direct | 6,557 Reduced 11.02% |
$301,622
$46.0 p/Share
|
Oct 21
2024 |
GIM
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 32,871 Reduced 0.0% |
$278,746
$8.48 p/Share
|
Oct 21
2024 |
BIGZ
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 64,641 Added 0.0% |
$490,625
$7.59 p/Share
|
Oct 21
2024 |
BCAT
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 28,670 Reduced 0.0% |
$466,460
$16.27 p/Share
|
Oct 21
2024 |
CEV
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 31,551 Reduced 0.0% |
$341,066
$10.81 p/Share
|
Oct 21
2024 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 9 Added 0.0% |
$9,624
$1069.4 p/Share
|
Oct 21
2024 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.04% |
$3,209
$1069.75 p/Share
|
Oct 21
2024 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 884 Added 0.0% |
$1,900
$2.15 p/Share
|
Oct 21
2024 |